Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05162326
PHASE1

BC-101 in Treatment of Nasolabial Fold Wrinkles

Sponsor: Bright Cell, Inc.

View on ClinicalTrials.gov

Summary

This is an open-label, single-arm, dose-escalating study to evaluate the safety and tolerability of BC-101 administered via subcutaneous/intradermal injection in the treatment of moderate to severe nasolabial folds.

Official title: A Phase 1/2 Study of the Safety and Efficacy of BC-101 in Treatment of Nasolabial Fold Wrinkles Via Subcutaneous/Intradermal Injection

Key Details

Gender

All

Age Range

40 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

9

Start Date

2026-12-01

Completion Date

2028-02-20

Last Updated

2025-12-29

Healthy Volunteers

No

Interventions

BIOLOGICAL

BC-101

Human umbilical cord tissue derived mesenchymal stem cells (hUC-MSC) suspension at concentration of 2, 4, or 6 million cells/mL.